DOCSLIB.ORG

Canna-Beer: All Your Favorite Vices in One Can,Cannabis Lab Testing

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Canna-Beer: All Your Favorite Vices in One Can,Cannabis Lab Testing Canna-beer: All your favorite vices in one can As cannabis grows in popularity, alcohol companies are adapting to the changing tide. The cannabis plant is closely related genetically to hops, so infused beers are a natural entrance for alcohol companies into the cannabis market. Several larger brands are making their own formulation of cannabis beverages, while others are investing in existing cannabis companies to meet the demands of adults who prefer to consume cannabis over alcohol in a social setting. This is a wonderful development for public health and safety, as cannabis holds none of the potential significant health risks that alcohol does. The inventor of Blue Moon beer will be launching three cannabis infused “beers” this fall in Colorado at his newly formed company Ceria. Keith Villa, who developed their famous Belgian wheat, has partnered with extracts company Ebbu to create a line of THC-infused drinks that have all the flavor of a beer, but none of the alcohol. They plan to release a spectrum of beers: a lager (with the lowest amount of THC), an ale (5-10mg THC) and an IPA (10-15mg THC). The president of Ebbu claims that they have refined their extraction process to deliver precise sensations that mimic alcohol, and hit the user at the same rate that beer does. Most edibles take 30 minutes to an hour for users to feel the effects, which can often lead to overconsumption and an unpleasant experience. A fast-acting beverage would help users accurately identify their tolerances and have a safe and pleasurable experience. These drinks should be launching between Thanksgiving and Christmas, just in time for the holidays. Available in Colorado Long time advocates of cannabis use, the team over at Lagunitas has recently come out with two cannabis-infused drinks. Their history with cannabis began in 1999, when they started hosting weekly brewery parties at 4:20pm. Later in 2001, they attempted to label one of their ales “Kronik,” which was censored by the Alcohol Tax and Trade Bueau (TTB), and aptly renamed “Censored.” Fast forward to 2014, when they came out with a two-part line named Night-time and Day-time, modeled after Indica and Sativa strains. In 2017, Lagunitas partnered with extraction company Absolute Xtracts and made two different products in a project called Supercritical: a hoppy beer infused with cannabis terpenes (which contain no cannabinoids), and a vape cartridge that contains hop terpenes extracted from their beer. Their most recent collaboration is a hoppy sparkling water named HiFi Hops, their first product containing actual cannabinoids. They have created two different formulations, one with 10mg THC and the other with 5mg THC and 5mg CBD. A balanced THC/CBD option is great for patients who have a lower edibles tolerance, but still prefer the relaxing effects of cannabis over the intoxicating effects of alcohol. Available in Colorado Colorado based company New Belgium has recently come out with the Hemperor IPA, or as they have nicknamed it, the HPA. Brewed with hemp hearts and dry hops, the developers of this beer have recreated the flavor profile of hemp terpenes without the terpenes themselves. It also contains no cannabinoids, which means that this beer is available for sale everywhere in the US! New Belgium is a dedicated advocate for the fight for hemp legalization, and donates to the national hemp legalization effort with every barrel of Hemperor sold. Check out their efforts by visiting thehemperor.com! Available nationwide (except Kansas) Cannabis Lab Testing Massachusetts has finally moved another step closer to the recreational sales its residents have been waiting for. Originally planned to begin on July 1, the slow moving licensing process has so far prevented all recreational sales. The Cannabis Commission that governs the state’s marijuana program has released seven provisional recreational retail licenses so far; however, there are still a number of hurdles to clear. The state took a big step forward this week when it issued two independent lab testing licenses, awarded to MCR labs in Framingham and CDX Analytics in Salem. These two facilities already test medical marijuana for the state’s cultivation centers and dispensaries, and hope to soon be testing the recreational product. Adult use dispensaries need to test all of their products with recreationally licensed labs and complete final building inspections and employee background checks before recreational purchases can begin. While it is great progress that these two lab licenses have been released, an unexpected issue has come to light about the way that these labs test their product. They use different methods, with each claiming that the other’s is incorrect. The state requires testing not only for cannabinoid profiles, but also for mold and bacteria content. MCR Labs employs a technique called plating, which involves taking a small sample of product and placing it in a petri dish with a medium that encourages the growth of microbes. After a determined period of time, the lab counts the number of colonies that grew from the sample and determines whether it exceeds the maximum amount allowed by the state. Plating is a widely used process generally recognized as the standard way to test for microbial content. CDX Analytics uses a process known as qPCR, which uses mass spectrometers and chromatograph machinery to determine the number of microbes by analyzing the DNA and measuring how many times the genetic codes of the microbes divide. This technology is newer and has been banned in Nevada for failing to identify known contaminants. Both CEOs from the two labs claim that the other is providing false results. CDX asserts that their test measures what is present in the sample in real time and gives a more accurate result for what the consumer will find on the shelf. They also declare that the plating method stifles the growth of some contaminants and encourages the growth of others, creating false positive results. This could lead to the increased use of pesticides and fungicides in the cultivation centers, which can be harmful to the consumer. MCR Labs, on the other hand, claims that the qPCR method is flawed in the way that it extrapolates the final number of microbes, therefore allowing products to go to market with contaminant levels that exceed the guidelines by the state. MCR Labs claims to fail approximately 30% of the samples they receive; CDX alleges they fail around 15%. This could become very risky because cultivators are more likely to send their samples to the lab that they think will give them passing marks. If either of these methods truly does provide incorrect results, consumers are at risk. So far, the Department of Health and Cannabis Commission have refused to take a position on either side of the argument. Reciprocity in RI On July 16, Rhode Island became one of the few progressive US states that allows full reciprocity with medical marijuana patients from other states. Several other states have existing reciprocity laws, but few of them are as allowing as little Rhody’s. Reciprocity is important for a number of reasons, the first of which for Rhode Islanders is tourism. With a large part of the economy in the Ocean State reliant on tourism, this added draw will only boost seasonal work and the sales tax collected on medical marijuana purchases. Another major reason to allow reciprocity is to allow full access to all kinds of cannabis formulations for patients whose home state may be more restrictive. Many patients in states like New York and New Jersey are in search of things like edibles and concentrates that some local governments don’t allow due to fears of overconsumption or appealing to children. States with Medical Reciprocity: Rhode Island — Patients must bring a physical card (not a paper certificate or online recommendation) as well as a driver’s license from the same state as their medical license. All states in the US are allowed. Patients may possess up to 2.5 ounces. Washington DC — Allows for patients from 16 different states to shop in their dispensaries with paper or physical card and a driver’s license. California is not on the approved list, greatly reducing the number of out-of-state patients who could be serviced in the nation’s capital. New Hampshire — Out-of-state patients can possess legally in the state, however they may not purchase from the state’s dispensaries. Patient’s can possess up to 2 ounces, and they must have a qualifying condition listed under New Hampshire’s medical marijuana legislation. Arizona — Like New Hampshire, patients may possess, but can’t visit any local dispensaries. Patients may possess up to 2.5 ounces. State’s with adult use legalization: California — Now allowing retail sales to adults 21 years and older, you can possess up to 28.5g (about one ounce) or 5g of concentrate. Colorado — The first state in the country to allow adult use sales, Colorado allows out-of-staters to possess up to an ounce, and you can only purchase a quarter ounce at a time. Washington — Closely following Colorado with full legalization, Washington has very thorough guidelines for its possession limits. One may have up to an ounce of flower, 16 ounces of solid infused edibles, 72 ounces of infused drinks and 7 ounces of concentrates. Maine — After legalizing cannabis in 2016, Maine has been slow to roll out its adult-use program. It is legal to possess and use cannabis in the state, but retail sales have been slower to implement due to local government pushback. You can possess up to 2.5 ounces in the state either as a medical card or adult user.
Load more

Recommended publications
  • The Green Regulatory Arbitrage
    Table of Contents I. EXECUTIVE SUMMARY ...................................................................................................... 1 II. PROHIBITION - HOW CANNABIS BECAME ILLEGAL ..................................................... 4 III. THE LEGAL LANDSCAPE .................................................................................................... 7 A. Federal Law And Its Impact On The Cannabis Industry ..................................................... 7 1. Cannabis Is A Schedule 1 Substance ............................................................................ 7 2. Access To Capital Markets Restricted ......................................................................... 9 3. Banking Services Limited .......................................................................................... 10 4. Tax Burdens .............................................................................................................. 11 5. Interstate And International Commerce Restrictions ................................................. 11 6. Insurance Options Limited ........................................................................................ 12 7. Medical Research And Clinical Trials Stymied .......................................................... 12 8. Professional Services Harder To Find ........................................................................ 13 9. Real Estate Challenges .............................................................................................. 13 B. The States
    [Show full text]
  • Harvest Health & Recreation Inc
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number 000-56224 HARVEST HEALTH & RECREATION INC. (Exact name of Registrant as specified in its Charter) British Columbia 84-3264202 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 1155 W. Rio Salado Parkway Suite 201 Tempe, Arizona 85281 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (480) 494-2261 Securities registered pursuant to Section 12(b) of the Act: Trading Title of each class Symbol(s) Name of each exchange on which registered N/A Securities registered pursuant to Section 12(g) of the Act: Subordinate Voting Shares Multiple Voting Shares Super Voting Shares Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES ☐ NO ☒ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. YES ☐ NO ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • NABCA Daily News Update (2/6/2019) 2
    Control State News February 6, 2019 Montgomery Co., MD: Franchot, Kramer Trade Sharp Jabs over JOB OPPORTUNITY Roles with Alcohol Businesses Virginia ABC ID: Business is growing for Idaho State Liquor Division Director of Communications NH: New Hampshire marijuana bill gets public hearing The Director of Communications serves as the primary media spokesperson for the agency, and PA: What’s fresh in the latest Pa. bill to legalize cannabis for as the point of contact for media issues for all recreational use? divisions. This position is required to work with executive staff and board members on MT: Bill taps into longer hours for breweries development and approval of statements and releases as needed. License State News For more details, click here. AK: New legislation would save beer and wine at the Alaska Brittany Burrell, MHRM, SHRM-CP | Talent State Fair Acquisition Consultant Virginia ABC | 2901 Hermitage Road, Richmond, MO: City council considers regulating drink specials VA 23220 Office: (804) 204-2319 International News Fax: (804) 213-4437 [email protected] Ireland: Social media putting young people off alcohol, www.abc.virginia.gov C&C warned SAVE THE DATE United Kingdom: NHS data shows rise in alcohol-related deaths March 17-19, 2019 Public Health News 26th Annual Symposium on Alcohol Beverage Law and Regulation New Research Further Explores Alcohol's Role as a Migraine Registration is open for NABCA’s 2019 Legal Symposium. Trigger For program details, travel information and to register online, please click here. Alcohol-Related Liver Disease Is Affecting New Demographics Global public health challenges, fiscal policies, and yellow vest NABCA HIGHLIGHTS Industry News The Public Health Considerations of Fetal Alcohol Spectrum Disorders (White Paper) How Wine Retailers Can Compete in The Age of Amazon Native American Nations & State Alcohol Brewers are ready for the low-ABV revolution.
    [Show full text]
  • Cansortium Inc
    CANSORTIUM INC. (the “Company” or the “Issuer”) Form 2A LISTING STATEMENT June 19, 2020 TABLE OF CONCORDANCE Informatio n Required by Form 2A Listing Statement Issuer Response 1. Table of Contents 2 2. Corporate Structure 2-5 3. General Development of the Business 5-8 4 Narrative Description of the Business 8-16 5. Selected Consolidated Financial Information 16-17 6. Management's Discussion and Analysis 17 Annual MD&A 17 Interim MD&A 17 7. Market for Securities 17 8. Consolidated Capitalization 18 9. Options to Purchase Securities 18-23 10. Description of the Securities 23-25 11. Escrowed Securities 26 12. Principal Shareholders 27-28 Table of 13 Directors and Officers 28-34 1. Contents 14. Capitalization 34-35 15. Executive Compensation 35-41 16. Indebtedness of Directors and Executive Officers 41-42 17. Risk Factors 42-73 18. Promoters 73 19. Legal Proceedings 73-74 20. Interest of Management and Others in Material Transactions 74-75 21. Auditors, Transfer Agents and Registrars 75 22. Material Contracts 76-77 23 Interest of Experts 77 24. Other Material Facts 78 25. Financial Statements 78 28. Schedule “B” 79-80 26. Certificate of the Issuer 81 27. Schedule “A” 2 Informatio n Required by Form 2A Listing Statement Issuer Response Corporate Structure 2.1 Name CANSORTIUM INC. 2.2 Incorporating The Company was incorporated under the laws of the Province of Ontario, Canada pursuant to the Business Corporations Act (Ontario) on Statute August 31, 2018. 3 2.3 Intercorporate Relationships 4 Informatio n Required by Form 2A Listing Statement Issuer Response 2.4 Requalifying / Not applicable Fundamental Change 2.5 Non- corporate / Not applicable non-Canadian Issuers 3.
    [Show full text]
  • May 2019 (Vol. XXXI, No. 2)
    the bar Back issues from 2000 to the present and a comprehensive, searchable index are available THE NEWSLETTER OF THE online at www.westbar.org/thesidebar. sideWESTMORELAND BAR ASSOCIATION VOLUME XXXI, NUMBER 2 MAY 2019 Survey of Judicial Candidates Six Vie for County’s Court of Common Pleas Nominations Kyle M. Wayne P. Jessica Matt Michael J. Justin Baxter McGrew Rafferty Schimizzi Stewart II Walsh ditor’s note: As in past judicial elections, we have — Membership in other organizations, including made space available for all the candidates for the positions held and length of membership. ECourt of Common Pleas of Westmoreland County 3. Describe your practice, identifying particular areas to respond to a series of uniform questions, hoping that the of expertise, if any, and how your practice breaks down effort enables our colleagues to learn a little bit more about by percentage in areas of real estate, personal injury, those who seek a seat on the bench. insurance defense, general litigation, family law, etc. The questions we posed are: 4. If you claim litigation experience as a qualification, 1. What is the municipality of your residence? provide the names of three members of the bar who 2. Submit a CV that includes the following information have sufficient knowledge and/or experience regarding (The CV should be sent to the WBA with the understanding your litigation skills (Please make certain the three that it will be posted on its website [www.westbar.org] for individuals have consented to have their names listed viewing by our readers and the public.): in the sidebar in this fashion).
    [Show full text]
  • 1 Cansortium Inc. Selected Financial Information And
    CANSORTIUM INC. SELECTED FINANCIAL INFORMATION AND MANAGEMENT’S DISCUSSION AND ANALYSIS The following management’s discussion and analysis (“MD&A”) provides information concerning the financial condition and results of operations of Cansortium Inc. (the “Company”). This MD&A is provided as of May 27, 2021 unless otherwise stated, and should be read along with the Cansortium Inc. Financial Statements (“Condensed Interim Consolidated Financial Statements”) and the accompanying notes for the three months ended March 31, 2021 and 2020. The results reported herein have been prepared in accordance with IFRS and, unless otherwise noted, are expressed in United States thousands of dollars. The Condensed Interim Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries and the Company’s interests in affiliated companies (see “Basis of consolidation” section within this MD&A). All intercompany balances and transactions have been eliminated on consolidation. This MD&A includes non-IFRS financial measures, such as “Adjusted gross profit”, “Adjusted gross margin”, “EBITDA”, “Adjusted EBITDA”, “EBITDA margin” and “Adjusted EBITDA margin”, as defined below. The management of the Company believes that these non-IFRS financial measures, in addition to conventional measures prepared in accordance with IFRS, provide information that is helpful to understand the results of operations and financial condition of the Company. The objective is to present readers with a view of the Company from the management’s perspective by interpreting the material trends and activities that affect the operating results, liquidity, and financial position of the Company. These measures are not necessarily comparable to similarly titled measures used by other companies.
    [Show full text]
  • August 29, 2019 Unless Otherwise Stated, and Should Be Read Together with the Cansortium Inc
    CANSORTIUM INC. SELECTED FINANCIAL INFORMATION AND MANAGEMENT’S DISCUSSION AND ANALYSIS The following management’s discussion and analysis (“MD&A”) provides information concerning the financial condition and results of operations of Cansortium Inc. (the “Company”). This MD&A is provided as of August 29, 2019 unless otherwise stated, and should be read together with the Cansortium Inc. unaudited condensed interim consolidated financial statements and the accompanying notes for the three and six months ended June 30, 2019 and 2018 (the “Condensed Interim Consolidated Financial Statements”) and the Cansortium Holdings LLC audited consolidated financial statements and the accompanying notes for the years ended December 31, 2018 and 2017 (the “Consolidated Financials Statements”). The results reported herein have been prepared in accordance with IFRS and, unless otherwise noted, are expressed in United States thousands of dollars. The Condensed Interim Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries and the Company’s interests in affiliated companies (see “Basis of consolidation” section within this MD&A). All intercompany balances and transactions have been eliminated on consolidation. This MD&A includes non-IFRS financial measures, such as “Adjusted gross profit”, “Adjusted gross margin”, “Pro-forma revenue”, “Pro-forma adjusted gross profit”, “Pro-forma adjusted gross margin”, “Pro-forma income (loss) from operations”, “EBITDA”, “Adjusted EBITDA”, “EBITDA margin” and “Adjusted EBITDA margin”, as defined below. The management of the Company believes that these non-IFRS financial measures, in addition to conventional measures prepared in accordance with IFRS, provide information that is helpful to understand the results of operations and financial condition of the Company.
    [Show full text]